Stock Events

OtsukaLtd. 

€43.8
2
+€0.2+0.46% Today

Statistics

Day High
43.8
Day Low
43.8
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
23.55B
P/E Ratio
28.55
Dividend Yield
1.6%
Dividend
0.7

Upcoming

Dividends

1.6%Dividend Yield
10Y Growth
-2.72%
5Y Growth
-3.95%
3Y Growth
-5.22%
1Y Growth
-2.04%

Earnings

9AugConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Next
-0.08
0.24
0.57
0.9
Expected EPS
0.7959139712
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow OS1.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap169.83B
Pfizer is a global pharmaceutical company that competes with Otsuka in various therapeutic areas, including psychiatric and neurological disorders.
Johnson & Johnson
JNJ
Mkt Cap372.29B
Johnson & Johnson, through its pharmaceutical segment, competes directly with Otsuka in the development and marketing of drugs for various conditions.
Novartis
NVS
Mkt Cap232.42B
Novartis is a leading healthcare company that competes with Otsuka in several areas, including neuroscience and digital health solutions.
GSK
GSK
Mkt Cap81.55B
GlaxoSmithKline competes with Otsuka in the pharmaceutical sector, particularly in the development of medications for psychiatric conditions.
Abbvie
ABBV
Mkt Cap304.29B
AbbVie competes with Otsuka in the neuroscience domain, particularly in the development of treatments for psychiatric disorders.
Merck &
MRK
Mkt Cap318.55B
Merck & Co. competes with Otsuka in the healthcare sector, focusing on pharmaceuticals that address critical areas of health.
Takeda Pharmaceutical
TAK
Mkt Cap42.51B
Takeda Pharmaceutical Company competes with Otsuka, especially in Japan and in the field of neuroscience, sharing a similar market focus.
Rogers
ROG
Mkt Cap2.34B
Roche Holding AG competes with Otsuka in the pharmaceutical and diagnostics sectors, particularly in areas like personalized healthcare.
Astrazeneca
AZN
Mkt Cap244.04B
AstraZeneca competes with Otsuka in various therapeutic areas, including the development of treatments for diseases in oncology and cardiovascular.
Bristol-Myers Squibb
BMY
Mkt Cap86.44B
Bristol Myers Squibb competes with Otsuka in the pharmaceutical sector, particularly in the development of innovative medicines for serious diseases.

About

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, and insecticide and toiletry products. In addition, the company offers IT solution services; adhesive tapes; flaky titanate and compounds; IV solutions; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; urinary tract health products; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. Otsuka Holdings Co., Ltd. was founded in 1921 and is headquartered in Tokyo, Japan.
Show more...
CEO
Mr. Tatsuo Higuchi
Employees
34388
Country
JP
ISIN
JP3188220002
WKN
000A1C9KC

Listings